YAYemisirach Bizuneh Akililu

Yemisirach Bizuneh Akililu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yemisirach Bizuneh Akililu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Spinal cord schistosomiasis: A case report

    by Abdulsemed Mohammed Yasin, Yemisirach Bizuneh Akililu, Betelhem Getahun, Chrstian Ayele Leta, Seida Mohammed, Milcah Eyoel Haileyesus

  • Open Access

    Surgical management and outcome of medulloblastoma patients at Addis Ababa between 2010 and 2018

    by Yemisirach B. Akililu, Eric Bouffet, Mersha Abebe

    Background: Medulloblastoma is the most common malignant central nervous system tumor in pediatric patients and is relatively rare in adults. Despite remarkable improvement in survival over recent decades, the high success rates in management documented in the Western world are not mirrored in middle- and low-income countries, due to various socio-economic factors and health-care disparities. Objective: The aim of this study was to assess surgical treatment outcome and prognostic factors in operated patients with medulloblastoma in Tikur Anbessa Specialized Hospital and Myungsung Christian Medical Center, the 2 largest neurosurgical units in Ethiopia. Methods: This retrospective study involved 27 patients (21 children and 6 adolescent or young adults) who underwent surgery for medulloblastoma between January 2010 and April 2018. A structured questionnaire was used to collect patients’ data and their treatment outcomes. Results: the 6 months and 1-year overall survival (OS) were 41% and 29% respectively, with a median survival time of 107 days (95% CI: 49,166). Median OS was 66 days (95% CI: 27,105), with 6 months and one-year OS rate of 24% for pediatric patients. Younger age at presentation, postoperative open EVD, longer Intensive Care Unit stay, lack of radiation treatment & postoperative complications were negative predictors of outcome. Conclusion: This experience underscores the high number of undiagnosed patients with medulloblastoma in Ethiopia and the poor outcome of patients who undergo active treatment. Standardization of treatment with surgery, craniospinal irradiation ± chemotherapy yields longer survival rates in both pediatric and adult patients.


  • Open Access

    Diabetic ketoacidosis (DKA) induced cerebral edema complicating small chronic subdural hematoma/hygroma/ at Zewuditu memorial hospital: a case report

    by Mestet Yibeltal Shiferaw, Tsegazeab Laeke T/Mariam, Abenezer Tirsit Aklilu, Yemisirach Bizuneh Akililu, Bethelhem Yishak Worku

    While both DKA & CSDH/subdural hygroma/ are known to cause significant morbidity and mortality, there is no a study that shows the role & effect of DKA on CSDH/subdural hygroma/ & vice versa to authors’ best knowledge; hence this work will show how important relation does exist between DKA & CSDH/ hygroma. This study highlights the diagnostic & management challenges seen for a case of a 44 years old female black Ethiopian woman admitted with a diagnosis of newly diagnosed type 1 DM with DKA + small CSDH/subdural hygroma/ after she presented with sever global headache and a 3 month history of lost to her work. She needed burrhole & evacuation for complete clinical improvement besides DKA’s medical treatment. DKA induced cerebral edema on the CSDH/subdural hematoma/ can have a role in altering any of the parameters (except the thickness of CSDH) for surgical indication of patients with a diagnosis of both CSDH +DM with DKA. Hence, the treating physicians should be vigilant of different parameters that suggests tight brain &/ cerebral edema (including midline shift, the status of cisterns, fissures & sulci) and should not be deceived of the thickness of the CSDH/subdural hygroma/alone; especially when there is a disproportionately tight brain for the degree of collection. Whether DKA induced cerebral edema causes a subdural hygroma is unknown and needs further study.


  • Open Access

    Multiple site neural tube defects at Zewuditu Memorial Hospital, Addis Ababa, Ethiopia: a case report

    by Mestet Yibeltal Shiferaw, Atalel Fentahun Awedew, Tsegazeab Laeke T/Mariam, Abenezer Tirsit Aklilu, Yemisirach Bizuneh Akililu, Aemiro Mazengia Andualem

    Background: Neural tube defects are common group of central nervous system anomalies of complex etiology and major public health importance worldwide. The occurrence of multiple neural tube defects, however, is an extremely rare event and has never been reported in Ethiopia so far. This study gives an insight into how the embryogenesis, management, and postoperative complications of multiple neural tube defects differ from the ordinary single neural tube defects on the basis of up-to-date existing literature. Case presentation: This paper highlights a case of an 8 days old female black race Ethiopian neonate who was brought by her mother with the chief complaint of lower back and lower neck swelling since birth. The findings were a 5 × 4 × 5 cm sized ulcerated placode at the mid-lumbosacral area and a 1.5 × 1.5 × 1 cm sized fluctuant, nontender, transilluminating mass with overlying unruptured defect dysplastic skin at the cervicothoracic junction. With a diagnosis of multiple neural tube defects secondary to unruptured cervicothoracic meningocele and ruptured lumbosacral myelomeningocele, single-stage repair of the defects was done with good outcome. Conclusion: There is insufficient evidence as to the exact mechanism of development of multiple neural tube defects. Similarly, whether patients with multiple neural tube defects had increased risk of post repair hydrocephalus compared with patients who have single neural tube defect is unknown. Hence, more research on the embryogenesis, management, and long-term outcome of multiple neural tube defects in particular and single neural tube defects in general should be done to better help patients with this costly and crippling problem. Lastly, the practice of folic acid supplementation is very low in resource-limited countries such as Ethiopia and, hence, should be improved.